ARA-290
Erythropoietin-derived 11-mer that targets the innate repair receptor. Studied for neuropathic pain in sarcoidosis and diabetic neuropathy.
At a glance
- Common vial size
- 14 mg
- Reference dose
- 4 mg
- Frequency
- Daily × 28 days, cycled
Reference titration protocol
4 mg daily during a 28-day cycle.
| Step | Dose | Duration | Administrations / week |
|---|---|---|---|
| 1 | 4 mg | 4 weeks | 7× |
A 14 mg vial reconstituted with 2 mL of bacteriostatic water yields 7 mg/mL. Confirm the diluent and volume against the labeling that ships with the vial.
Open this configuration in the calculatorAvailable formulations
Presentations carried across the VitaRelay pharmacy network, including 503A compounded, 503B outsourcing facility, and research & development sourcing. Pricing and state-level availability are shown to verified accounts only.
- 0 · Lyophilized PowderRUO
- 100 mg/5ml · Injectable503A
- Lyophilized PowderRUO
References
Often used with
Compounds commonly discussed alongside ARA-290 in published protocols and prescriber requests. Listed for reference only — not a clinical recommendation, and not a suggestion to co-administer.
- BPC-157503A503BRUO
Discussed together in neuropathic recovery protocols.
31 presentations carried - Methylene Blue503A503BRUO
Mitochondrial-support adjunct discussions.
5 presentations carried - TB-500503A503BRUO
Also used in healing & recovery protocols.
6 presentations carried - GHK-Cu503A503BRUO
Also used in healing & recovery protocols.
9 presentations carried
Pricing and ordering are for verified accounts
VitaRelay serves licensed practices, prescribers, and pharmacies. Catalog pricing, availability by state, and ordering are available after your account is verified.
